期刊文献+

难治性高血压

Diagnosis and treatment of refractory hypertension
原文传递
导出
摘要 高血压患者中约10%-15%被分类为难治性高血压^[1,2],现明确难治性高血压常常伴有亚临床器官损害和高发额外心血管(CV)危险^[2],难治性高血压的治疗仍面临着严峻的挑战,本文拟就近年认识的难治性高血压的定义,发生原因及处理意见等问题进行简要综述。
作者 孙有祖
出处 《中国热带医学》 CAS 2009年第1期58-59,共2页 China Tropical Medicine
  • 相关文献

参考文献11

  • 1Tamimi N AM. Resistant hypertension: a methodologicat approach to diagnosis and treatment[J]. Saudi J Kidney Dis Transplant. 2007, 18: 337-345.
  • 2Mancia G, de Backer G, Dominiczak A, et al.2007 Guidelines for the management of arterial Hypertension, the task force for the European society of hypertension (ESH) and of the European society of Cardielogy(ESC)[J]. J Hypertension.2007,25:1105-1187.
  • 3中国高血压防治指南修订委员会.中国高血压防治指南(2005年修订版).高血压杂志,2005,134:2-2.
  • 4Campese VM, Mitr A, Sandee D. Hypertension in renal parendymal disease Why is it so resistant to treatment?[J]. Kidney Int, 2006, 69: 967-973.
  • 5Epstein M, Calboun DA. The role of aldosterone in resistant hypertension implication for pathogenesis and therapy [J]. Curr Hypertens Rep. 2007, 9:98-105.
  • 6Good friend TL, Calhcun DA. Resistant hypertension, obesity, steep apnea, and albosterone theory and therapy [J]. Hypertension, 2004, 43:518-524.
  • 7Moser M, Setaro JF. Resistant or difficult-control hypertension [J]. N Engl J Med. 2006, 355:385-392.
  • 8Mancia G, de Backer G, dominiczak A, et al. 2007 Guidelines for the management of arterial Hypertension, the task force for the ESH/ESC [J]. J Hypertension . 2007, 25:1105-1187.
  • 9Epstein M, Calboun DA. The role of aldosterone in resistant hypertension implication for pathogenesis and therapy [J]. Curr Hypertension Rep, 2007, 9:98-105.
  • 10Epstein M, Calhoun DA. The role of aldosterone in resistant hypertension: implication for pathogenesis and therapy [J]. Curr Hyperten Rep. 2007, 9:98-105.

共引文献507

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部